GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma

GPX2 overexpression indicates poor prognosis in patients with hepatocellular carcinoma

Glutathione peroxidase 2 has important role of tumor progression in lots of carcinomas, yet little is known about the prognosis of glutathione peroxidase 2 in hepatocellular carcinoma. Glutathione peroxidase 2 expression was assessed by immunohistochemistry in hepatocellular carcinoma tissues. The a...

Full description

Bibliographic Details
Main Authors:	Ting Liu, Xue-feng Kan, Charlie Ma, Li-li Chen, Tian-tian Cheng, Zhen-wei Zou, Yong Li, Feng-jun Cao, Wen-jie Zhang, Jing Yao, Pin-dong Li
Format:	Article
Language:	English
Published:	IOS Press 2017-06-01
Series:	Tumor Biology
Online Access:	https://doi.org/10.1177/1010428317700410

Similar Items

The overexpression of GPX8 is correlated with poor prognosis in GBM patients
by: Sibo Li, et al.
Published: (2022-08-01)

TRIP13 overexpression in hepatocellular carcinoma: implications for poor prognosis and immune cell infiltration
by: Jiapeng Xue, et al.
Published: (2023-09-01)

eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma
by: Shi-Lu Chen, et al.
Published: (2018-02-01)

PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma
by: Jun Liu, et al.
Published: (2022-11-01)

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma
by: Yibing Chen, et al.
Published: (2018-12-01)

Overexpression of Aurora Kinase B Is Correlated with Diagnosis and Poor Prognosis in Hepatocellular Carcinoma
by: Jin Zhang, et al.
Published: (2024-02-01)

GPX3 Overexpression in Cumulus Cells Entails a Poor Prognosis for Uterine Implantation of Morphotype A Embryos
by: Ignacio Bejarano, et al.
Published: (2022-09-01)

Overexpression of LILRA2 indicated poor prognosis of ovarian carcinoma: A new potential biomarker and therapeutic target
by: Yixin Zhang, et al.
Published: (2023-01-01)

Overexpression of RALY promotes migration and predicts poor prognosis in hepatocellular carcinoma
by: Zhu Z, et al.
Published: (2018-11-01)

Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
by: Jiang J, et al.
Published: (2021-03-01)

Increased Expression of CAP2 Indicates Poor Prognosis in Hepatocellular Carcinoma
by: Jia Fu, et al.
Published: (2015-10-01)

Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis.
by: Yu-Ling Chen, et al.
Published: (2013-01-01)

LCMT1 indicates poor prognosis and is essential for cell proliferation in hepatocellular carcinoma
by: Ning Zhang, et al.
Published: (2023-01-01)

SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma
by: Hao-Wen Chuang, et al.
Published: (2021-10-01)

Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma
by: Yu-Hsuan Kuo, et al.
Published: (2021-09-01)

Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer
by: M. Li, et al.

GPX4 and GPX7 over-expression in human hepatocellular carcinoma tissues
by: E. Guerriero, et al.
Published: (2015-12-01)

Decrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis.
by: Rongzhen Luo, et al.
Published: (2013-01-01)

Underexpression of Deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma
by: Kaiyan Yang, et al.
Published: (2008-07-01)

Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis
by: Long Liu, et al.
Published: (2023-07-01)

Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.
by: Bei Liu, et al.
Published: (2012-01-01)

High expression of agrin is associated with tumor progression and poor prognosis in hepatocellular carcinoma
by: Qi-Jia Zhang, et al.
Published: (2019-08-01)

CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis
by: Xuefeng Gu, et al.
Published: (2019-10-01)

Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
by: Ting Liu, et al.
Published: (2023-10-01)

Overexpression of tousled-like kinase 2 predicts poor prognosis in HBV-related hepatocellular carcinoma patients after radical resection
by: Bang Liu, et al.
Published: (2024-01-01)

Overexpression of TNFSF11 reduces GPX4 levels and increases sensitivity to ferroptosis inducers in lung adenocarcinoma
by: Zizhen Li, et al.
Published: (2024-04-01)

Overexpression of MTFR2 Predicts Poor Prognosis of Breast Cancer
by: Lu W, et al.
Published: (2020-11-01)

Overexpressed pepsinogen C is associated with poor prognosis in human hepatocellular carcinoma: a tissue microarray study
by: Chen H, et al.
Published: (2019-04-01)

VEGF overexpression predicts poor survival in hepatocellular carcinoma
by: Choi Sae Byeol, et al.
Published: (2017-12-01)

Role of Microtubule-Associated Protein 1b in Urothelial Carcinoma: Overexpression Predicts Poor Prognosis
by: Tsu-Ming Chien, et al.
Published: (2020-03-01)

Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer
by: Zhang J, et al.
Published: (2022-03-01)

Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma.
by: Jian Liu, et al.
Published: (2016-01-01)

Overexpression of OAS1 Is Correlated With Poor Prognosis in Pancreatic Cancer
by: Lingling Lu, et al.
Published: (2022-07-01)

Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma
by: Li D, et al.
Published: (2020-06-01)

Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients.
by: Yan Li, et al.
Published: (2017-01-01)

Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma
by: Peng Chen, et al.
Published: (2019-11-01)

Overexpression of RASAL1 indicates poor prognosis and promotes invasion of ovarian cancer
by: Chang Rui-Xia, et al.
Published: (2019-05-01)

High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma.
by: Shi-Hong Zhang, et al.
Published: (2013-01-01)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
by: Qinglin Ding, et al.
Published: (2022-10-01)

High expression of PARD3 predicts poor prognosis in hepatocellular carcinoma
by: Songwei Li, et al.
Published: (2021-05-01)